Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter Open Access June 1, 2011

Diabetes insipidus due to pituitary metastasis in a woman with lung adenocarcinoma: a case report

  • Chen-Hao Hsiao EMAIL logo , Chung-Yih Wang , Ming-Teng Chung and Ming-Sung Yang
From the journal Open Medicine

Abstract

Metastatic tumors of the pituitary are uncommon and usually asymptomatic. They are often incidental findings from imaging workups for other medical issues or from the assessment of primary tumors in other locations. Diabetes insipidus is the most common symptom resulting from pituitary tumors, including pituitary metastases. A 56-year-old woman with primary lung adenocarcinoma underwent video-assisted thoracic bilobectomy. Regular follow-up was unremarkable until 15 months after surgery, when she presented with polyuria and polydipsia suggestive of diabetes insipidus. A pituitary mass was found on brain magnetic resonance imaging; the diagnosis of lung adenocarcinoma metastasized to the pituitary was confirmed by trans-sphenoidal surgery and biopsy of the pituitary mass. Diabetes insipidus and hormonal profiles are the key to recognize the existence of pituitary metastases, and patients with primary lung cancers presenting with diabetes insipidus should be evaluated for pituitary metastases.

[1] McCormick P.C., Post K.D., Kandji A.D., Hays A.P., Metastatic carcinoma to the pituitary gland, Br J Neurosurg., 1989, 3, 71–80 http://dx.doi.org/10.3109/0268869890900102810.3109/02688698909001028Search in Google Scholar PubMed

[2] Komninos J., Vlassopoulou V., Protopapa D., Korfias S., Kontogeorgos G., Sakas D.E., et al., Tumors metastatic to the pituitary gland: case report and literature review, J Clin Endocrinol Metab., 2004, 89, 574–580 http://dx.doi.org/10.1210/jc.2003-03039510.1210/jc.2003-030395Search in Google Scholar PubMed

[3] Rajput R., Bhansali A., Dutta P., Gupta S.K., Radotra B.D., Bhadada S., Pituitary metastasis masquerading as non-functioning pituitary adenoma in a woman with adenocarcinoma lung, Pituitary., 2006, 9, 155–157 http://dx.doi.org/10.1007/s11102-006-8326-010.1007/s11102-006-8326-0Search in Google Scholar PubMed

[4] Sioutos P., Yen V., Arbit E., Pituitary gland metastases, Ann Surg Oncol., 1996, 3, 94–99 http://dx.doi.org/10.1007/BF0240905810.1007/BF02409058Search in Google Scholar PubMed

[5] Nelson P.B., Robinson A.G., Martinez A.J., Metastatic tumor of the pituitary gland, Neurosurgery., 1987, 21, 941–944 http://dx.doi.org/10.1227/00006123-198712000-0003010.1227/00006123-198712000-00030Search in Google Scholar PubMed

[6] Krol T.C., Wood W.S., Bronchogenic carcinoma and diabetes insipidus: case report and review, Cancer., 1982, 49, 596–599 http://dx.doi.org/10.1002/1097-0142(19820201)49:3<596::AID-CNCR2820490332>3.0.CO;2-810.1002/1097-0142(19820201)49:3<596::AID-CNCR2820490332>3.0.CO;2-8Search in Google Scholar

[7] Morita A., Meyer F.B., Laws E.R. Jr., Symptomatic pituitary metastases, J Neurosurg., 1998, 89, 69–73 http://dx.doi.org/10.3171/jns.1998.89.1.006910.3171/jns.1998.89.1.0069Search in Google Scholar

[8] Marin F., Kovacs K.T., Scheithauer B.W., Young W.F. Jr., The pituitary gland in patients with breast carcinoma: a histologic and immunocytochemical study of 125 cases, Mayo Clin Proc., 1992, 67, 949–956 10.1016/S0025-6196(12)60925-2Search in Google Scholar

[9] Teears R.J., Silverman E.M., Clinicopathologic review of 88 cases of carcinoma metastatic to the pituitary gland, Cancer., 1965, 36, 216–220 http://dx.doi.org/10.1002/1097-0142(197507)36:1<216::AID-CNCR2820360123>3.0.CO;2-E10.1002/1097-0142(197507)36:1<216::AID-CNCR2820360123>3.0.CO;2-ESearch in Google Scholar

[10] Branch C.L. Jr., Laws E.R. Jr., Metastatic tumors of the sella tunica masquerading as primary pituitary tumors, J Clin Endocrinol Metab., 1987, 65, 469–474 http://dx.doi.org/10.1210/jcem-65-3-46910.1210/jcem-65-3-469Search in Google Scholar

[11] Chandra V., McDonald L.W., Anderson R.J., Metastatic small cell carcinoma of the lung presenting as pituitary apoplexy and Cushing’s syndrome, J Neurooncol., 1984, 2, 59–66 http://dx.doi.org/10.1007/BF0016515910.1007/BF00165159Search in Google Scholar PubMed

[12] Sanno N., Teramoto A., Osamura R.Y., Genka S., Katakami H., Jin L., et al., A growth hormonereleasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly, J Clin Endocrinol Metab., 1997, 82, 2731–2737 http://dx.doi.org/10.1210/jc.82.8.273110.1210/jc.82.8.2731Search in Google Scholar

[13] Jerome Marson V., Mazieres J., Groussard O., Garcia O., Berjaud J., Dahan M., et al., Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade, Histopathology., 2004, 45, 125–134 http://dx.doi.org/10.1111/j.1365-2559.2004.01893.x10.1111/j.1365-2559.2004.01893.xSearch in Google Scholar PubMed

[14] Coons S.W., Estrada S.I., Gamez R., White W.L., Cytokeratin CK 7 and CK 20 expression in pituitary adenomas, Endocr Pathol., 2005, 16, 201–210 http://dx.doi.org/10.1385/EP:16:3:20110.1385/EP:16:3:201Search in Google Scholar

Published Online: 2011-6-1
Published in Print: 2011-8-1

© 2011 Versita Warsaw

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 29.3.2024 from https://www.degruyter.com/document/doi/10.2478/s11536-011-0040-2/html
Scroll to top button